Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
PRA Health Sciences revenue increased from $3.1 billion in 2019 to $3.2 billion in 2020, a (3.8%) increase.

Annual Revenue ($)

PRA Health Sciences revenue was $3.18 b in FY, 2020 which is a (3.8%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2018FY, 2019FY, 2020
Revenue$2.87 b$3.07 b$3.18 b
Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021
Revenue$722.02 m$763.31 m$780.69 m$783.71 m$729.89 m$796.31 m$933.78 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

PRA Health Sciences revenue breakdown by business segment: 91.8% from Clinical Research and 8.2% from Data Solutions

PRA Health Sciences revenue breakdown by geographic segment: 31.5% from Europe, Africa, and Asia-Pacific, 67.6% from United States and 0.8% from Other

FY, 2018FY, 2019FY, 2020
Clinical Research$2.81 b$2.81 b$2.92 b
Data Solutions$253.29 m$253.29 m$260.32 m
FY, 2018FY, 2019FY, 2020
Europe, Africa, and Asia-Pacific$862.3 m$935.39 m$1 b
Americas (excluding USA)$47.12 m$48.67 m$26.58 m
United States$1.96 b$2.08 b$2.15 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu